Essential involvement of interleukin‐8 (IL‐8) in acute inflammation
…, N Sekido, T Akahoshi, T Wada… - Journal of leukocyte …, 1994 - Wiley Online Library
Neutrophil infiltration into inflammatory sites is one of the hallmarks of acute inflammation.
Locally produced chemotactic factors are presumed to mediate the sequence of events …
Locally produced chemotactic factors are presumed to mediate the sequence of events …
[HTML][HTML] Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy
T Wada, K Furuichi, N Sakai, Y Iwata, K Yoshimoto… - Kidney international, 2000 - Elsevier
… Author links open overlay panel Takashi Wada , Kengo Furuichi , Norihiko Sakai , Yasunori
Iwata , Keiichi Yoshimoto , Miho Shimizu , Shin-Ichi Takeda , Kazuya Takasawa , Mitsuhiro …
Iwata , Keiichi Yoshimoto , Miho Shimizu , Shin-Ichi Takeda , Kazuya Takasawa , Mitsuhiro …
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
…, T Tsukamoto, S Uchida, T Wada… - Arthritis & …, 2022 - Wiley Online Library
Objective To develop and validate revised classification criteria for granulomatosis with
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into …
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into …
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis
…, T Tsukamoto, S Uchida, T Wada… - Arthritis & …, 2022 - Wiley Online Library
Objective To develop and validate revised classification criteria for eosinophilic granulomatosis
with polyangiitis (EGPA). Methods Patients with vasculitis or comparator diseases were …
with polyangiitis (EGPA). Methods Patients with vasculitis or comparator diseases were …
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
…, T Tsukamoto, S Uchida, T Wada… - Arthritis & …, 2022 - Wiley Online Library
Objective To develop and validate classification criteria for microscopic polyangiitis (MPA).
Methods Patients with vasculitis or comparator diseases were recruited into an international …
Methods Patients with vasculitis or comparator diseases were recruited into an international …
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
…, G Bakris, J Bauersachs, H Haller, T Wada… - European heart …, 2021 - academic.oup.com
This review covers the last 80 years of remarkable progress in the development of
mineralocorticoid receptor (MR) antagonists (MRAs) from synthesis of the first mineralocorticoid to …
mineralocorticoid receptor (MR) antagonists (MRAs) from synthesis of the first mineralocorticoid to …
Trajectories of kidney function in diabetes: a clinicopathological update
…, T Toyama, A Hara, K Furuichi, T Wada - Nature Reviews …, 2021 - nature.com
Diabetic nephropathy has been traditionally diagnosed based on persistently high albuminuria
and a subsequent decline in glomerular filtration rate (GFR), which is widely recognized …
and a subsequent decline in glomerular filtration rate (GFR), which is widely recognized …
2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
…, T Tsukamoto, S Uchida, T Wada… - Arthritis & …, 2022 - Wiley Online Library
Objective To develop and validate new classification criteria for Takayasu arteritis (TAK).
Methods Patients with vasculitis or comparator diseases were recruited into an international …
Methods Patients with vasculitis or comparator diseases were recruited into an international …
[HTML][HTML] A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy
…, H Makino, K Kimura, Y Suzuki, T Wada… - Clinical and …, 2015 - Springer
… .; Takashi Wada has received speaker honoraria from pharmaceutical company Daiichi-Sankyo
Co., Ltd., scholarship grants from Chugai pharmaceutical Co., Ltd.; Susumu Ogawa has …
Co., Ltd., scholarship grants from Chugai pharmaceutical Co., Ltd.; Susumu Ogawa has …
Blockade of CCR2 ameliorates progressive fibrosis in kidney
K Kitagawa, T Wada, K Furuichi, H Hashimoto… - The American journal of …, 2004 - Elsevier
Fibrosis is a hallmark of progressive organ diseases. Monocyte chemoattractant protein (MCP)-1,
also termed as macrophage chemotactic and activating factor (MCAF/CCL2) and its …
also termed as macrophage chemotactic and activating factor (MCAF/CCL2) and its …